A Model for Troponin I as a Quantitative Predictor of In-Hospital Mortality

Journal of the American College of Cardiology

Volumn 48, Issue 9, 2006, Pages 1755-1762

  Waxman, Daniel A ^a   Hecht, Susan ^a   Schappert, Joseph ^a,b   Husk, Gregg ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HEALTH CENTER; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL;

AGED; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TROPONIN I;

EID: 33750451227     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.05.075     Document Type: Article

References (34)

1. Koerbin G., Tate J.R., Potter J.M., and Hickman P.E. The comparative analytical performance of four troponin I assays at low concentration. Ann Clin Biochem 42 (2005) 19-23
2. Gibler W.B., Cannon C.P., Blomkalns A.L., et al. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement. Circulation 111 (2005) 2699-2710
3. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
4. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144 (2002) 981-986
5. Panteghini M., Pagani F., Yeo K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 50 (2004) 327-332
6. Sheehan P., Blennerhassett J., and Vasikaran S.D. Decision limit for troponin I and assay performance. Ann Clin Biochem 39 (2002) 231-236
7. Apple F.S., Murakami M.M., Pearce L.A., and Herzog C.A. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
8. Aviles R.J., Askari A.T., Lindahl B., et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346 (2002) 2047-2052
9. Henrikson C.A., Howell E.E., Bush D.E., et al. Prognostic usefulness of marginal troponin T elevation. Am J Cardiol 93 (2004) 275-279
10. Kontos M.C., Shah R., Fritz L.M., et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 43 (2004) 958-965
11. Morrow D.A., Cannon C.P., Rifai N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 286 (2001) 2405-2412
12. Zethelius B., Johnston N., and Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 113 (2006) 1071-1078
13. Husk G., and Waxman D.A. Using data from hospital information systems to improve emergency department care. Acad Emerg Med 11 (2004) 1237-1244
14. Sauerbrei W., and Royston P. Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. Journal of the Royal Statistical Society: Series A (Statistics in Society) 162 (1999) 71-94
15. Hosmer D., and Lemeshow S. Applied Logistic Regression. 2nd edition (2000), Wiley, New York, NY 100-104
16. Robertson C., Boyle P., Hsieh C.C., Macfarlane G.J., and Maisonneuve P. Some statistical considerations in the analysis of case-control studies when the exposure variables are continuous measurements. Epidemiology 5 (1994) 164-170
17. Ai C., and Norton E.C. Interaction terms in logit and probit models. Economics Letters 80 (2003) 123-129
18. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
19. Apple F.S., Murakami M.M., Quist H.H., Pearce L.A., Wieczorek S., and Wu A.H. Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values. Am J Clin Pathol 120 (2003) 114-120
20. Diderholm E., Andren B., Frostfeldt G., et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. Am Heart J 143 (2002) 760-767
21. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., and Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 38 (2001) 478-485
22. Lindahl B., Diderholm E., Lagerqvist B., Venge P., Wallentin L., and FRISC II (Fast Revascularization during InStability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 38 (2001) 979-986
23. Newby L.K., Christenson R.H., Ohman E.M., et al., The GUSTO-IIa Investigators. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 98 (1998) 1853-1859
24. Ohman E.M., Armstrong P.W., Christenson R.H., et al., GUSTO IIA Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 335 (1996) 1333-1341
25. Dokainish H., Pillai M., Murphy S.A., et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 45 (2005) 19-24
26. Ammann P., Maggiorini M., Bertel O., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 41 (2003) 2004-2009
27. Apple F.S., and Murakami M.M. Serum 99th percentile reference cutoffs for seven cardiac troponin assays. Clin Chem 50 (2004) 1477-1479
28. Giannitsis E., and Katus H.A. 99th percentile and analytical imprecision of troponin and creatine kinase-MB mass assays: an objective platform for comparison of assay performance. Clin Chem 49 (2003) 1248-1249
29. Schwarzenberger J.C., Sun L.S., Pesce M.A., et al. Sex-based differences in serum cardiac troponin I, a specific marker for myocardial injury, after cardiac surgery. Crit Care Med 31 (2003) 689-693
30. Royston P., Altman D.G., and Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25 (2006) 127-141
31. Riou B., Dreux S., Roche S., et al. Circulating cardiac troponin T in potential heart transplant donors. Circulation 92 (1995) 409-414
32. Allison P.D. Comparing logit and probit coefficients across groups. SMR/Sociological Methods & Research 28 (1999) 186-208
33. Apple F.S., Maturen A.J., Mullins R.E., et al. Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem 45 (1999) 206-212
34. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663